Observational Study of Meloxicam in Any Labeled Indication

Boehringer Ingelheim

Status: Completed

Conditions: Arthritis, Rheumatoid

Treatments: Drug: Meloxicam

Study type: Observational

Funder types: Industry

Identifiers

NCT02182739

107.249

Details and patient eligibility

About

Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.

Enrollment: 13,039 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients according to the physicians medical criteria on the labeled indications for Meloxicam

Exclusion criteria

• none

Trial design

13,039 participants in 1 patient group

Meloxicam

Treatment:

Drug: Meloxicam